Milestone Scientific, Inc. (MLSS) Reports Q3 Loss of $0.07
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Milestone Scientific Reports Third Quarter 2015 Financial Results and Provides Business Update
November 11, 2015 4:05 PM ESTLIVINGSTON, NJ -- (Marketwired) -- 11/11/15 -- Milestone Scientific Inc. (NYSE: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced financial results for the third quarter ended September 30, 2015 and provided a business update including an update on its minority owned subsidiary which holds the exclusive rights to the epidural and intra-articular (IA) instruments ("Epidural & IA Subsidiary").
Leonard Osser, Chief Executive Officer of Milestone Scientific, stated, "Our... More
